Labor Unions, Advocates: Don't Move on Cures Without Drug Pricing Reforms

October 26, 2016 at 8:56 PM

Moving forward with the 21st Century Cures legislation in the lame duck session would be a “missed opportunity” to recraft the bill next Congress to deal with drug pricing, argues a coalition of groups including labor unions and consumer and patient advocates in a letter sent to House and Senate Democratic leadership and the ranking Democrats on two key committees Wednesday (Oct. 26).


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.